Aurora Cannabis Inc. (TSX: ACB)

Market Cap	326.31M
Revenue (ttm)	296.99M
Net Income (ttm)	-43.68M
Shares Out	54.84M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	278,027
Open	5.90
Previous Close	5.83
Day's Range	5.77 - 5.98
52-Week Range	3.84 - 12.85
Beta	2.71
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Aurora Cannabis

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2013
• Employees: 1,073
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: ACB

Financial Performance

In 2023, Aurora Cannabis's revenue was 270.28 million, an increase of 20.77% compared to the previous year's 223.80 million. Losses were -65.58 million, -91.97% less than in 2022.